Malaria Transmission and Immunity in Highland Kenya
1 other identifier
observational
20,610
1 country
1
Brief Summary
The purpose of this study is to see why malaria epidemics occur in highland areas in Kenya. A better understanding of factors contributing to malaria may be necessary for malaria vaccine planning. These factors include interactions between age, where malaria is passed from mosquitoes to people, immune system (how the body fights infection) responses and other factors that contribute to malaria in epidemic-prone areas. About 6400 people from the villages of Kapsisiywa and Kipsamoite will participate. Study procedures will include in home surveys, which will involve a census and an interview by researchers. Blood samples and smears will be collected from some volunteers in both communities to understand how the body protects itself from malaria and to check for malaria parasites. Twice each month, random houses will be selected from 3 places in the village to measure the number of mosquitoes in the home. Participants may be involved in the study for up to 4 years.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2006
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2006
CompletedFirst Submitted
Initial submission to the registry
October 26, 2006
CompletedFirst Posted
Study publicly available on registry
October 30, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2011
CompletedFebruary 1, 2019
October 1, 2007
4.3 years
October 26, 2006
January 30, 2019
Conditions
Keywords
Eligibility Criteria
You may qualify if:
- Active surveillance of clinical malaria -Individuals of any age who live in the area (Kipsamoite or Kapsisiywa) for more than 6 months of the year, or, if they are new to the area, who plan to live in the area for more than 6 months of the year (permanent residents).
- Passive surveillance of clinical malaria
- Any individual living within the boundaries of the 2 study areas (Kipsamoite and Kapsisiywa)
You may not qualify if:
- Active surveillance of clinical malaria
- Declining to participate in the study
- Will be gone from site more than 1 week per month
- Not available for weekly symptom check or bimonthly blood sample collection
- Passive surveillance of clinical malaria
- Declining to participate in the study
- Participation in active surveillance study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kenya Medical Research Institute
Kisumu, 40100, Kenya
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- NIH
Study Record Dates
First Submitted
October 26, 2006
First Posted
October 30, 2006
Study Start
October 1, 2006
Primary Completion
January 31, 2011
Study Completion
January 31, 2011
Last Updated
February 1, 2019
Record last verified: 2007-10